Caronna, Edoardo
Pozo-Rosich, Patricia http://orcid.org/0000-0003-0796-4702
Article History
Accepted: 9 August 2021
First Online: 11 November 2021
Compliance with Ethical Standards
:
: Dr Caronna has received honoraria from Novartis and Chiesi. Dr Pozo-Rosich has received honoraria as a consultant and speaker for the following: Allergan-AbbVie, Almirall, Biohaven, Chiesi, Eli Lilly, Medscape, Neurodiem, Novartis, and Teva. Her research group has received research grants from Novartis and has received funding for clinical trials from Alder, Amgen, Electrocore, Eli Lilly, Novartis, Teva. She is a trustee member of the board of the International Headache Society and the Council of the European Headache Federation. She is on the editorial board of Revista de Neurologia. She is an editor for Cephalalgia, Headache, Neurologia, Frontiers of Neurology, and advisor for The Journal of Headache and Pain. She is a member of the Clinical Trials Guidelines Committee of the International Headache Society. She has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society. She is the founder of ExternalRef removed. PP-R does not own stocks from any pharmaceutical company. The authors declare no conflict of interest in regard to this manuscript.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.